AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca and Merck's ovarian cancer drug Lynparza has received U.S. regulatory approval for the treatment of advanced pancreatic cancer, cementing its lead in a niche category of cancer treatments.


from Reuters: Health News https://ift.tt/2u3L38V

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says